British Columbia Investment Management Corp Illumina, Inc. Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

A detailed history of British Columbia Investment Management Corp transactions in Illumina, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 26,575 shares of ILMN stock, worth $3.62 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

26,575

Previous 30,432 12.67%

Holding current value

$3.62 Million

Previous $3.18 Million 9.1%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$105.28 - $135.9 $406,064 - $524,166	-3,857 Reduced 12.67%	26,575 $3.47 Million
Q2 2024 Aug 14, 2024	BUY	$101.05 - $133.57 $1.16 Million - $1.53 Million	11,473 Added 60.51%	30,432 $3.18 Million
Q1 2024 May 14, 2024	BUY	$127.73 - $147.2 $94,264 - $108,633	738 Added 4.05%	18,959 $2.6 Million
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $356,035 - $546,887	3,837 Added 26.68%	18,221 $2.54 Million
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $17,918 - $26,749	139 Added 0.98%	14,384 $1.97 Million
Q2 2023 Aug 11, 2023	BUY	$183.43 - $232.67 $38,336 - $48,628	209 Added 1.49%	14,245 $2.67 Million
Q1 2023 May 12, 2023	BUY	$193.75 - $232.55 $19,762 - $23,720	102 Added 0.73%	14,036 $3.26 Million
Q4 2022 Feb 10, 2023	SELL	$187.24 - $242.74 $292,843 - $379,645	-1,564 Reduced 10.09%	13,934 $2.82 Million
Q3 2022 Nov 10, 2022	SELL	$177.23 - $227.44 $480,647 - $616,817	-2,712 Reduced 14.89%	15,498 $2.96 Million
Q2 2022 Aug 12, 2022	SELL	$181.58 - $368.0 $855,604 - $1.73 Million	-4,712 Reduced 20.56%	18,210 $3.36 Million
Q1 2022 May 12, 2022	SELL	$303.87 - $423.8 $862,079 - $1.2 Million	-2,837 Reduced 11.01%	22,922 $8.01 Million
Q4 2021 Feb 11, 2022	SELL	$347.28 - $421.83 $434,099 - $527,287	-1,250 Reduced 4.63%	25,759 $9.8 Million
Q3 2021 Nov 12, 2021	BUY	$405.61 - $524.84 $5,678 - $7,347	14 Added 0.05%	27,009 $11 Million
Q2 2021 Aug 09, 2021	BUY	$372.84 - $481.5 $1.14 Million - $1.47 Million	3,059 Added 12.78%	26,995 $12.8 Million
Q1 2021 Apr 30, 2021	SELL	$361.28 - $504.76 $277,101 - $387,150	-767 Reduced 3.1%	23,936 $9.19 Million
Q4 2020 Feb 02, 2021	SELL	$292.7 - $370.96 $231,525 - $293,429	-791 Reduced 3.1%	24,703 $9.14 Million
Q3 2020 Nov 10, 2020	BUY	$268.51 - $400.74 $520,372 - $776,634	1,938 Added 8.23%	25,494 $7.88 Million
Q2 2020 Aug 12, 2020	BUY	$256.46 - $373.01 $1.92 Million - $2.79 Million	7,474 Added 46.47%	23,556 $8.72 Million
Q1 2020 May 13, 2020	SELL	$209.2 - $335.53 $3.89 Million - $6.24 Million	-18,606 Reduced 53.64%	16,082 $4.39 Million
Q4 2019 Feb 12, 2020	BUY	$288.29 - $335.49 $4.17 Million - $4.86 Million	14,474 Added 71.6%	34,688 $11.5 Million
Q3 2019 Nov 14, 2019	SELL	$266.84 - $378.23 $2.05 Million - $2.9 Million	-7,673 Reduced 27.51%	20,214 $6.15 Million
Q2 2019 Aug 12, 2019	BUY	$300.59 - $368.15 $109,414 - $134,006	364 Added 1.32%	27,887 $10.3 Million
Q1 2019 May 08, 2019	SELL	$272.57 - $321.18 $3.71 Million - $4.37 Million	-13,618 Reduced 33.1%	27,523 $8.55 Million
Q4 2018 Feb 13, 2019	SELL	$272.46 - $366.54 $2.99 Million - $4.03 Million	-10,989 Reduced 21.08%	41,141 $12.3 Million
Q3 2018 Nov 13, 2018	SELL	$279.04 - $367.06 $1.45 Million - $1.9 Million	-5,184 Reduced 9.04%	52,130 $19.1 Million
Q2 2018 Aug 09, 2018	BUY	$228.17 - $292.07 $544,869 - $697,463	2,388 Added 4.35%	57,314 $16 Million
Q1 2018 May 15, 2018	SELL	$209.54 - $253.91 $654,183 - $792,707	-3,122 Reduced 5.38%	54,926 $13 Million
Q4 2017 Feb 20, 2018	BUY	$202.23 - $230.03 $1.46 Million - $1.66 Million	7,202 Added 14.16%	58,048 $12.7 Million
Q3 2017 Nov 14, 2017	BUY	$172.3 - $213.93 $8.76 Million - $10.9 Million	50,846	50,846 $10.1 Million

Others Institutions Holding ILMN

# of Institutions

908

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Illumina, Inc. Transaction History